A randomized, single-blind, parallel prospective confirmatory clinical trial to compare and evaluate the efficacy of galvanic vestibular stimulation (GVS) on vestibular compensation and spatial cognitive function in patients with acute and chronic unilateral or bilateral vestibular dysfunction

Jeonbuk National University Hospital0 个研究点目标入组 90 人开始时间: 待定最近更新: 2022年3月8日

试验速览

暂无简介。

•A. Patients who meet the diagnostic criteria for acute unilateral vestibular dysfunction (Acute UVD)
•B. Chronic unilateral vestibular dysfunction (Chronic UVD) Patients who meet the following criteria
•C. Patients who meet the diagnostic criteria for bilateral vestibular dysfunction (BVD)
•D. Those who have a history of causing vestibular dysfunction and cognitive decline or have no history of neurodegenerative diseases such as stroke or dementia
•E. A person who can understand the research contents, follow instructions, and can communicate
•F. Those who consented to participation in the study and follow-up
•G. 20 years old or older and less than 70 years old

•A. Those who show abnormal findings in neurological examination
•B. A person with a structural abnormality of the brain
•C. There are other clinically serious diseases (cerebrovascular disease, cardiopulmonary disease, liver disease, kidney disease, malignancy, musculoskeletal disease, psychiatric disease and neurodegenerative disease that can affect cognitive function)
•D. Those who are taking medications for epilepsy or have a history of convulsions
•E. Women of childbearing potential and pregnant women
•F. Persons with dermatological diseases, scars, or trauma at the site of application of the medical device
•G. Persons who have installed metal devices inside and outside the body (considering those who cannot take MRI)
•H. Those who do not agree to participate in the research
•I. Subjects who participated in similar clinical trials within the last year

发起方